← Evidence map

ArticleMolecular therapy. Methods & clinical development2025

Antibodies to recombinant human alpha-L-iduronidase prevent disease correction in cortical bone in MPS I mice.

Sarah C Hurt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 40123743